3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
5
Myeloproliferative Disorders
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Leukemia, Myelomonocytic, Chronic
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Multiple Myeloma
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Anxiety Disorders
1
Amyotrophic Lateral Sclerosis
1
Advanced Malignant Solid Tumors
1
Advanced Lung Cancer
1
Advanced Breast Cancer
1
Interventions
Cyclophosphamide
11
Biopsy
11
Specimen Handling
10
Rituximab
9
Magnetic Resonance Spectroscopy
9
obinutuzumab
6
fludarabine
6
Prednisone
6
Lenalidomide
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
X-Rays
4
Doxorubicin
4
venetoclax
3
fludarabine phosphate
3
Vincristine
3
Tacrolimus
3
Mycophenolic Acid
3
GSK2636771
3
Etoposide
3
Busulfan
3
Bendamustine Hydrochloride
3
trametinib
2
tocilizumab
2
palbociclib
2
osimertinib
2
ipatasertib
2
ibrutinib
2
glofitamab
2
erdafitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Injections
×
30 days
×
Clear all
No trials found.